MAP6 and Cognitive impairment: MAP6-KO mice displayed a large spectrum of behavioural and cognitive impairments associated with neurotransmission and synaptic alterations23, 28, 30, 43, which have been shown to positively respond to long-term typical and atypical neuroleptic treatment23, 31, 32.